Brainsway Home

Chi siamo		Technology		Media		Applications		Clinical Trials		Publications		News & Events		FAQ		Investors

Deep TMS - A unique technology for non-invasive treatment of brain disorders

Initial Focus:

Non-invasive treatment of clinical depression

For Italian Issues please contact:

Ruggero Nessim Raccah, M.D.

ATID ltd Advanced Technology Innovation Distribution, Rome, Italy,

tel +39 335 6283079 www.atidtech.com

The Technology

	Transcranial magnetic stimulation (TMS) is a noninvasive technique used to apply brief magnetic pulses to the brain. The pulses are administered by passing high currents through an electromagnetic coil placed upon the patient's scalp...
Ulteriori informazioni

Applications

	The unique technology of Brainsway Deep TMS enables non-invasive excitation or inhibition of practically any brain structure, in any deep or cortical brain region. Thus, a broad range of brain disorders may potentially be treated with this method.
Ulteriori informazioni

Notizie
30 April, 3009 Brainsway Announces Signing of Memorandum of Understanding to Market the Deep TMS Device in Italy
16 September, 2009 Knockdown of brain-derived neurotrophic factor in specific brain sites precipitates behaviors associated with depression and reduces neuroge
7 September, 2009 Brainsway Announces Receipt of Italian Ministry of Health Approval for Marketing and Sale of Deep TMS Device in Italy
3 September, 2009 Brainsway Receives Approval for Marketing of Deep TMS Device for the Treatment of Manic Depression

Active Clinical Trials

A Prospective Multicenter Double Blind Randomized Controlled Trial to Explore Safety and Efficacy in Major Depression

15 medical centers in the USA, Canada, Europe and Israel

Smoking cessation in chronic obstructive pulmonary disease

Beer Yaacov , Israel

Contact: Limor Klein 054-3301324 The Trial is under supervision of Prof Pinhas Danon & Dr. Oded Rosenberg

Altzheimer's Disease

Ichilov Medical Center at Tel Aviv , Israel

Contact: Amit Ginou: (972)-2-5824030

Depression Maintenance

Shalvata Mental Health Center, Hod-Hasharon, Israel

Contact: Dr. Yechiel Levkovitz, 050-6264624

Bipolar Disorder - Double-Blind Placebo Control

Shalvata Mental Health Center, Hod-Hasharon, Israel

Contact: Dr. Yechiel Levkovitz, 050-6264624

Schizophrenia : Auditory Hallucinations

Beer Yaacov Mental- Health Center, Beer Yaacov, Israel

Contact: Dr. Oded Rosenberg, 054-7502109 Stimulation Unit phone: טלפון ביחידת גרייה : 08-9284293 Research center secretary Phone: טלפון מזכירות מחקר: 08-9258396

Post Traumatic Stress Disorder (PTSD)

Hadassah Ein-Karem Hospital, Jerusalem, Israel

Contact: Dr. Moshe Isserlish, 02-6779308

Schizophrenia - Double-Blind Placebo Control

Shalvata Mental Health Center, Hod-Hasharon, Israel

Contact: Dr. Yechiel Levkovitz, 050-6264624

Parkinson's Disease

Sheba Medical Center, Tel-Hashomer Hospital , Tel Hashomer, Israel

Contact: Amit Ginou (972)-2-5824030

Autism

Psychiatry Research Centre The Alfred Hospital and Monash University, Melbourne, Vic, Australia

Contact: Prof. Paul B Fitzgerald and Dr. Peter Enticott Alfred Tel: + 61 3 9076 6595 , Fax: + 61 3 9076 6588

Copyright 2009 @ Brainsway. Address: 19 Hartum st. Bynet Building, 1st floor, Har Hotzvim, Jerusalem, ISRAEL, zip code: 91451 Tel: 972-2-5813140, Fax: 972-2-5812517, Email: infobr@brainsway.com For Italian Issues please contact: Ruggero Nessim Raccah, M.D., ATID Ltd Advanced Technology Innovation Distribution, Rome, Italy. www.atidtech.com Created by Catom.